Blog
    Peptide SpotlightFor PatientsApril 1, 2026

    Ipamorelin, Sermorelin, and CJC-1295: What is the difference?

    Learn how Ipamorelin, Sermorelin, and CJC-1295 work to trigger growth hormone release and what the current research says about their safety and side effects.

    If you have spent five minutes looking into peptides, you have probably seen these three names thrown around like the starting lineup of a sports team. They all try to do the same basic thing: nudge your brain into making more growth hormone.

    Think of growth hormone as your body's internal maintenance crew. It helps repair stuff. As we get older, that crew starts taking longer lunch breaks. These peptides are essentially a tap on the shoulder to tell them to get back to work.

    Sermorelin is the seasoned veteran here. It was actually approved by the FDA years ago to help children who weren't growing properly. It works by mimicking a natural signal in your body that tells your pituitary gland—a tiny, pea-sized organ at the base of your brain—to release growth hormone.

    Next is Ipamorelin. If Sermorelin is a tap on the shoulder, Ipamorelin is more like a specific text message. It is very selective, meaning it triggers growth hormone pulses without accidentally messing with other hormones like cortisol (your stress hormone) or prolactin. Most scientists think of it as a cleaner way to get the job done, though we are still waiting on big studies to prove it helps with things like fat loss in everyday people.

    Then there is CJC-1295. This one is built for the long haul. While the others might stay in your system for an hour or two, CJC-1295 can hang around for six to eight days. It binds to a common protein in your blood to stay active longer. This is a great one to bring up with your doctor. You can find peptide-experienced physicians in our Find a Doctor directory.

    But here is the part where I have to be the bearer of reality. While these sound great, the science is still catching up. For example, one major study on CJC-1295 was stopped entirely after a participant died. We also have zero clinical proof that taking Ipamorelin and CJC-1295 together—a very common 'stack' you'll see online—actually does anything better or safer. Scientists are still working on this one—turns out the human body is complicated. Who knew?

    This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.

    Referenced Peptides

    This content was generated from TruthTides clinical reference data. It does not constitute medical advice. Always consult a qualified healthcare provider.